Insulin IgG antibodies
Insulin antibodies can be measured together with other markers of islet cell autoimmunity (GAD65, IA2, ZNT8 antibodies) to predict the development and aid in the diagnosis of type 1 diabetes mellitus (T1DM). Two or more antibodies in combination increase the predictive value of disease development. Of these, insulin and GAD65 antibodies usually arise first. Insulin autoantibody development peaks at 1-2 years of age and is associated with the HLA DR4/DQ8 haplotype (Katsarou, A, et al. Type 1 diabetes mellitus. Nat Rev Dis Primers 3, 17016 (2017)).
Screening for diabetic autoantibodies is also used to distinguish between type 2 diabetes mellitus (T2DM) and latent autoimmune diabetes in adults (LADA) in the adult population.
Insulin antibodies can also develop following insulin treatment and can be a cause of resistance to insulin.
NICE Guidelines for the diagnosis of T1DM in adults (NG17) recommend measuring diabetes-specific autoantibodies at diagnosis and state that the false negative rate can be reduced if quantitative tests for two different diabetes specific antibodies are measured. The laboratory performs quantitative GAD65 and IA2 in house, where these are negative insulin antibodies may be requested.
Differential diagnosis of T2DM and LADA
Investigation of insulin resistance
Negative
Not currently performed in house; this test is referred to the Protein Reference Unit (PRU) in Sheffield.
Record last updated
August 21, 2025
Sample Container
5ml RST Vacutainers (Rust top)
Search test database
Test Results
Yes, we have a Pathology User Guide
Yes. Please email your request to Imperial.nwlpcustomerservice@nhs.net
Results are communicated to clinical staff and are normally not communicated direct to patients either on telephone requests or in written report. If you need to contact us please click here to view the contact details page
Please contact the Customer Service Team Monday to Friday from 8:30am – 6:00pm on 0203 313 5353. Alternatively, see the Pathology User Guide for how to contact the relevant department. If advice is not urgent you can also email your query to Imperial.nwlpcustomerservice@nhs.net
Additional tests may be added by discussion with the relevant laboratory. The time limit for adding additional tests to a sample already received in the laboratory will depend on the type of sample and the department it was sent to.
Information on the repertoire of tests performed by pathology, including reference ranges, turnaround times and specimen requirements, can be found in the test directory.
Phlebotomy services are not managed by NWLP. For further information please see:
Imperial College Healthcare Trust Phlebotomy services
Chelsea and Westminster Hospital NHS Foundation Trust Phlebotomy services
NWLP operates UKAS accredited medical laboratories as per the references below. The current scope of accreditation for all NWLP’s laboratories can be found on the UKAS website.
See the following UKAS ref numbers:
- Clinical Biochemistry Ref: 8673
- Haematology and Blood Transfusion Ref: 8674
- Infection & Immunity Sciences (Including Immunology, Virology, Microbiology and Histocompatibility and Immunogenetics ) Ref: 8659
- Cellular Pathology (Including Histopathology, Cytology and Molecular Pathology) Ref: 9615
If you require copies of our certificate of accreditation and associated documentation please contact Imperial.nwlpcustomerservice@nhs.net.
UKAS requires the laboratories to be accredited for a particular repertoire/scope (ISO15189), any changes or additions to repertoire require assessment by UKAS (extension to scope).
The BD Hospital Tube Guide, BD GP Tube Guide and BD Paediatric Tube Guide provide visual references to the correct tube types and collection instructions.
Home testing
INSTRUCTION SHEET FOR BLOOD SAMPLE COLLECTION
We also have two instruction videos available (one with subtitles and one without) – please click on the links to view the videos on Google.
Our accreditations
Upholding excellence in diagnostic standards
Our laboratories are accredited by the UK Accreditation Service (UKAS) against the international standard ISO15189:2022. UKAS is the accreditation body for the UK that assesses medical laboratories.
Find out more about our accreditations on the UKAS website.
UKAS website